Brief: Zoetis Announces Pricing Of $1.85 Billion Of Senior Notes
11/08/2025 23:49
Aug 11 (Reuters) - Zoetis Inc ZTS.N: ZOETIS ANNOUNCES PRICING OF $1.85 BILLION OF SENIOR NOTES ZOETIS INC - AGREED TO SELL CONSISTING OF $850.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 4.150% SENIOR NOTES DUE 2028 ZOETIS INC - AGREED TO SELL $1.0 BILLION AGGREGATE PRINCIPAL AMOUNT OF 5.000% SENIOR NOTES DUE 2035 Source text: ID:nBw3XG36ja Further company coverage: ZTS.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zoetis
See all newsBrief: Zoetis Receives FDA Approval For Convenia® Rtu For Dogs (Cefovecin Injectable Suspension), Helping More Medium And Large Dogs Access Single-Injection Treatment
Brief: FDA Approves Ready-To-Use Cefovecin Injectable For Treatment Of Certain Skin Infections In Dogs
U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan Materials
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs
Brief: FDA Issues Emergency Use Authorization For Simparica Trio To Treat New World Screwworm In Dogs, Puppies